Publications by authors named "Robyn Macfarlane"

Claim this Profile
P
Patient Perspectives of Quality Compared to Quantity of Life Regarding Orbital Exenteration.
Kalpesh Hathi, Colin MacKay, Robyn Macfarlane, S Mark Taylor

Otolaryngol Head Neck Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using quality improvement frameworks to develop, implement, and evaluate a novel ambulatory oncology pharmacy practice model: A descriptive example.
Hayley Underhill, Michael LeBlanc, Robyn Macfarlane, Lauren Hutton

Am J Health Syst Pharm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in-depth analysis on the effects of body composition in patients receiving neoadjuvant chemotherapy for urothelial cell carcinoma.
Landan MacDonald, Ricardo A Rendon, Myuran Thana, Lori Wood, Robyn MacFarlane

Can Urol Assoc J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-World Retrospective Analysis of the Management of Advanced Urothelial Carcinoma in Canada.
Feras A Moria, Changsu L Park, Bernhard J Eigl, Robyn Macfarlane, Michel Pavic

Curr Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the COVID-19 Pandemic on Medical Oncology Workload: A Provincial Review.
Margaret Sheridan, Bruce Colwell, Nathan W D Lamond, Robyn Macfarlane, Daniel Rayson

Curr Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.
Sebastien J Hotte, Kim N Chi, Anthony M Joshua, Donsheng Tu, Robyn J Macfarlane

Clin Genitourin Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.
Georg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, Denis Soulieres, D Scott Ernst, Robyn Jane Macfarlane

Eur J Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer.
Akira Watahiki, Robyn J Macfarlane, Martin E Gleave, Francesco Crea, Yuzhuo Wang

Int J Mol Sci· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing face of tumor phenotypes.
Robyn Macfarlane, Edward R Sauter

Biomark Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.
Luke A Selth, Scott Townley, Joanna L Gillis, Aleksandra M Ochnik, Krisna Murti, Robyn J Macfarlane

Int J Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor.
Robyn Macfarlane, Melanie Seal, Caroline Speers, Ryan Woods, Hamad Masoudi

Oncologist· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy.
Robyn Macfarlane, Daniel Y C Heng, Wanling Xie, Jennifer J Knox, David F McDermott

Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lapatinib for breast cancer: a review of the current literature.
Robyn J MacFarlane, Karen A Gelmon

Expert Opin Drug Saf· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series.
Pauline T Truong, Mary Lesperance, Karen Hui Li, Robyn MacFarlane, Caroline H Speers

Ann Surg Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel targeted therapies for prostate cancer.
Robyn J Macfarlane, Kim N Chi

Urol Clin North Am· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis.
Robyn J Macfarlane, Barbara J McCully, Conrad V Fernandez

Pediatr Nephrol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis